Idiopathic Thrombocytopenic Purpura CME: The France Foundation: ITP Community Case Exchange Series: 2008- Emerging Management Strategies for ITP: St Louis, MO: September 25, 2008
- By Idiopathic Thrombocytopenic Purpura (ITP)
- Published 09/5/2008
- Oncology , Hepatology , Hematology
- Unrated
ITP Community Case Exchange Series: 2008- Emerging Management Strategies for ITP
Idiopathic Thrombocytopenic Purpura (ITP)
This CME activity is part of a year long educational curriculum focused on idiopathic thrombocytopenic purpura (ITP), designed to provide evidence-based clinical information on the diagnosis and management of patients with ITP to hematologists, oncologists, and other health care professionals. For more ITP educational activities, please visit us at http://www.ITPeducation.com.
View All Postings by This Contributor.
The France Foundation
Location:
John Mineo's Italian Restaurant
St Louis, MO
Course Directors/Instructors:
Michael Tarantino, MD
Medical Director
Comprehensive Bleeding Disorders Center
University of Illinois College of Medicine
Peoria, IL
Course Fee:
Free
Number of Credits:
2 AMA PRA Category 1 Credit (s)™
Link
Detailed Description:
This interactive CME activity will begin with a lecture by an ITP expert titled "2008-Emerging Management Strategies for ITP". After questions are addressed, learners will have the opportunity to share and discuss their own patient cases with the expert and their peers participating in this activity.
For More Information, Call 866-856-1998.
Learning Objectives:
- Perform a differential diagnosis of ITP and identify the patients most likely to benefit from therapy
- Identify historical therapeutic strategies for ITP management and their relevant health risks and side effects
- Demonstrate knowledge of emerging therapies for ITP and their associated clinical evidence
- Utilize patient assessment and education tools to track therapeutic progress and improve compliance in ITP patients
- Develop an individualized management plan for each ITP patient based on history, risk factors, and platelet status
Spread The Word
Comments
No Comments Found.This review is the subjective opinion of a CME Networks site member or user and not of CME Networks, LLC.
CMENetworks.com Comment Policy: CMEnetworks.com encourages you to add a comment to this discussion. You may not post any unlawful, threatening, libelous, defamatory, obscene or other material that would violate the law. Please note that CMEnetworks.com may edit comments for clarity or to keep out questionable or off-topic material. All comments should be relevant to the post and remain respectful of other authors or commentors. By submitting your comment, you hereby give CMEnetworks.com the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying information via all forms of media now know or hereafter devised, worldwide, in perpetuity.




